Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Anatara Lifesciences Ltd ( (AU:ANR) ) has provided an update.
Anatara Lifesciences Limited has announced a change in the director’s interest notice concerning Dr. David Brookes. The company disclosed that Dr. Brookes has disposed of 932,143 unlisted options, with no new securities acquired. This change reflects adjustments in Dr. Brookes’ holdings, which include both direct and indirect interests through various trusts and superfunds. The announcement is part of the company’s compliance with ASX listing rules, ensuring transparency in the director’s financial interests.
More about Anatara Lifesciences Ltd
Average Trading Volume: 1,382,602
Technical Sentiment Signal: Sell
Current Market Cap: A$4.08M
For a thorough assessment of ANR stock, go to TipRanks’ Stock Analysis page.